Ординатура / Офтальмология / Английские материалы / Fundamentals of Clinical Ophthalmology Cornea_Coster_2002
.pdf
CORNEA |
|
|
|
● Squamous cell carcinoma of the cornea |
● |
Terrien’s dystrophy |
|
● |
Squamous papilloma |
● |
Thygeson’s punctate keratitis |
● |
Superior limbic keratoconjunctivitis |
● |
Vernal keratoconjunctivitis |
Acanthamoeba keratitis
Indication for treatment |
1. |
Alter natural history of disease: eradicate infection |
|
2. |
Symptomatic: decrease pain |
|
3. |
Decrease disability: reduce blinding sequelae of inflammation |
|
|
|
Preferred treatment |
1. |
Antiamoebic therapy: propamidine isothianate 0.1% |
|
2. |
Cycloplegia |
|
|
|
Alternative treatment |
Anti-amoebic therapy: polyhexamethylene biguanide 200 mg/ml |
|
|
|
|
Complications of treatment |
1. |
Drug toxicity |
|
2. |
Hypersensitivity |
|
|
|
Follow up |
Daily until healed |
|
|
|
|
Acute recurrent corneal erosion
Indication for treatment |
1. |
Symptomatic: relief of severe pain |
|
2. |
Alter natural history: achieve epithelial closure and prevent recurrence |
|
|
|
Preferred treatment |
1. |
Dilate pupil to reduce spasm |
|
2. |
Pad |
|
|
|
Alternative treatment |
Bandage contact lens |
|
|
|
|
Complications of treatment |
– |
|
|
|
|
Follow up |
daily until healed |
|
|
|
|
Adenoviral keratoconjunctivitis
Indication for treatment |
Symptomatic: to decrease pain and photophobia if severe |
|
|
|
|
Preferred treatment |
1. |
Prednisolone phosphate 0.5% four times/day then titrate against level of |
|
|
corneal inflammation. |
|
2. |
Only effective in controlling stromal inflammation. If the stroma is not |
|
|
involved this approach will not help. There is no place for antiviral therapy |
|
|
|
Alternative treatment |
Withhold ocular medication |
|
|
|
|
Complications of treatment |
Ocular hypertension |
|
|
|
|
Follow up |
Every two weeks then on topical corticosteroids to monitor intraocular pressure |
|
|
|
|
168
|
|
THERAPY OF CORNEAL DISORDERS |
Allergic conjunctivitis |
|
|
|
|
|
Indication for treatment |
Symptomatic: to reduce inflammation |
|
|
|
|
Preferred treatment |
1. |
Removal of the offending antigen (if known) |
|
2. Topical corticosteroids (short term to relieve acute symptoms). Prednisolone |
|
|
|
phosphate or |
|
3. Topical mast cell stabiliser – as a prophylactic treatment, e.g. topical |
|
|
|
lodexamide 0.1% or |
|
4. Topical H1 receptor antagonist, e.g. levocabastine 0.05% |
|
Alternative treatment |
– |
|
|
|
|
|
|
|
Complications of treatment |
Long term topical steroids are associated with glaucoma |
|
|
|
|
Follow up |
Review regularly if on topical corticosteroids |
|
|
|
|
Bacterial keratitis |
|
|
|
|
|
Indication for treatment |
1. Alter natural history of disease: eradicate infection |
|
|
2. Symptomatic: decrease pain |
|
|
3. Decrease disability: reduce blinding sequelae of inflammation |
|
|
|
|
Preferred treatment |
1. Antibiotics: cephalothin 50 mg/ml, gentamicin 14 mg/ml. Hourly for first |
|
|
|
24 hours, then hourly during the day for three days then four times a day for |
|
|
the next three days. Antibiotic choice modified following Gram stain, culture, |
|
|
clinical course |
|
2. Corticosteroids: prednisolone phosphate 0.5% 4/day after |
|
|
|
organism identified and favourable response to antibiotics |
|
|
|
Alternative treatment |
Ciprofloxacin or ofloxacin as alternative to cephalothin or gentamicin |
|
|
|
|
Complications of treatment |
1. |
Drug allergy |
|
2. |
Drug toxicity |
|
|
|
Follow up |
Daily until epithelium healed, then as required |
|
|
|
|
Chemical injury to cornea |
|
|
|
|
|
Indication for treatment |
1. Symptomatic: to overcome pain |
|
|
2. To improve natural history of disease by encouraging epithelial healing and |
|
|
|
reducing corneal inflammation and lysis |
|
|
|
Preferred treatment |
Emergency lavage of conjunctiva |
|
|
Pupil dilation – atropine 1% daily |
|
|
Topical antibiotics if infection threatens |
|
|
Topical corticosteroids (prednisolone phosphate 0.5%) if inflammation with |
|
|
white cell recruitment ensues |
|
|
|
|
Alternative treatment |
Acetyl cysteine and ascorbic acid are currently being assessed in clinical trials |
|
|
Amniotic membrane grafting is also being assessed |
|
|
|
|
Complications of treatment |
Toxicity. Excessive topical medication impairs wound healing, particularly |
|
|
epithelial healing |
|
|
|
|
Follow up |
1. Severe burns should be hospitalised |
|
|
2. Less severe cases need regular obsessive review, every 48–72 hours until |
|
|
|
epithelium has healed, then as required |
|
|
|
169
CORNEA
Corneal abrasions
Indication for treatment |
1. |
Symptomatic: pain, photophobia |
|
2. |
Alter natural history: encourage epithelial healing |
|
|
|
Preferred treatment |
1. |
Dilate pupil – homatropine 2% |
|
2. |
Pad |
|
|
|
Alternative treatment |
Prophylactic topical antibiotic, e.g. chloramphenicol 2/day until healed |
|
|
|
|
Complications of treatment |
Impeded epithelial healing, recurrent erosion, microbial keratitis |
|
|
|
|
Follow up |
Daily until healed |
|
|
One week later and examine angle and posterior segment |
|
|
|
|
Corneal foreign body
Indication for treatment |
1. |
Symptomatic: pain |
|
2. |
Alter natural history: encourage epithelial healing |
|
|
|
Preferred treatment |
1. |
Remove foreign body |
|
2. |
Prophylactic antibiotic, e.g. chloramphenicol twice daily until epithelium has |
|
|
healed |
|
3. |
Cycloplegia – homatropine 2% at time of foreign body removal |
|
|
|
Complications of treatment |
Perforation, microbial keratitis, recurrent erosion |
|
|
|
|
Follow up |
Daily until epithelium has healed |
|
|
|
|
Episcleritis
Indication for treatment |
To relieve the patient of symptoms of discomfort or redness |
|
|
Preferred treatment |
Topical steroids for 2–3 weeks |
|
|
Alternative treatment |
Mild cases – nothing |
|
Severe cases – oral flurbiprofen 100 mg 3/day or oral indomethacin 25 mg |
|
3/day |
|
|
Complications of treatment |
Gastritis secondary to non-steroidal anti-inflammatories |
|
|
Follow up |
May have recurrence and is seldom associated with a systemic disorder |
|
|
Filamentary keratitis |
|
|
|
Indication for treatment |
To relieve pain |
|
|
Preferred treatment |
Depends on the underlying cause |
|
1. Tear substitutes |
|
2. Mucolytic agents – acetyl cysteine 10% twice daily |
|
|
Follow up |
As symptoms demand |
|
|
170
|
|
THERAPY OF CORNEAL DISORDERS |
Fungal keratitis – filamentous organism |
||
|
|
|
Indication for treatment |
1. |
Alter natural history of disease: eradicate infection |
|
2. |
Symptomatic: decrease pain |
|
3. |
Decrease disability: reduce blinding sequelae of inflammation |
|
|
|
Preferred treatment |
1. |
Natamycin 5% drops |
|
2. |
Miconazole 1% drops |
|
|
Hourly for the first day |
|
|
Hourly during the day for the second day |
|
|
Then three hourly for the next five days |
|
|
Then as required |
|
|
|
Alternative treatment |
Other imidazole, e.g. fluconazole, ketaconazole |
|
|
Hourly for first day |
|
|
Hourly during day for second day |
|
|
|
|
Complications of treatment |
1. |
Sensitivity |
|
2. |
Toxicity |
|
|
|
Follow up |
Daily until healed |
|
|
|
|
Fungal keratitis – yeast
Indication for treatment |
1. Alter natural history of disease: eradicate infection |
|
|
2. |
Symptomatic: decrease pain |
|
3. |
Decrease disability |
|
|
|
Preferred treatment |
1. Antifungal: flucytosine 1% drops, miconazole 1% drops |
|
|
2. |
Oral flucytosine 100 mg/kg/day |
|
|
Drops hourly for first 24 hours |
|
|
Hourly during the day for the second day |
|
|
Then three hourly for the next five days |
|
|
Then as required |
|
|
|
Complications of treatment |
1. |
Sensitivity |
|
2. |
Toxicity |
|
|
|
Follow up |
Daily until healed |
|
|
|
|
Granuloma of limbus and conjunctiva
Indication for treatment |
Symptomatic: cosmesis, discharge |
|
|
Preferred treatment |
Prednisolone phosphate 0.5% four times/day |
|
|
Complications of treatment |
Elevated intraocular pressure |
|
|
Follow up |
Weekly until lesion has disappeared |
|
|
171
CORNEA
Herpetic dendritic ulceration
Indication for treatment |
To alter natural history of disease by encouraging epithelial healing |
|
|
|
|
Preferred treatment |
Oc Acyclovir five times a day until epithelium healed, then 3/day for three days |
|
|
|
|
Alternative treatment |
1. |
Other antivirals, e.g. triflurothymidine, idoxuridine |
|
2. |
Debridement plus antiviral |
|
|
|
Complications of treatment |
1. |
Allergy |
|
2. |
Toxicity |
|
|
|
Follow up |
Review regularly while on therapy |
|
|
|
|
Herpetic geographic ulceration
Indication for treatment |
To alter natural history of disease by encouraging epithelial healing |
|
|
|
|
Preferred treatment |
Oc Acyclovir 5/day until epithelium healed then 3/day for three days |
|
|
|
|
Alternative treatment |
Triflurothymidine 5/day until healed then 3/day for three days |
|
|
|
|
Complications of treatment |
1. |
Allergy |
|
2. |
Toxicity |
|
|
|
Follow up |
Review regularly while on therapy |
|
|
|
|
Herpetic stromal keratitis
Indication for treatment |
1. |
Symptomatic: to reduce pain |
|
2. |
Decrease disability: improve vision |
|
3. |
Alter natural history: reduce scarring |
|
|
|
Preferred treatment |
Topical corticosteroids with antiviral cover. Commence prednisolone phosphate |
|
|
0.5% 4/day and Oc acyclovir 3. Titrate steroid against inflammatory score. |
|
|
Reduce Oc acyclovir to 2/day after one week then daily at the end of the |
|
|
second week. Cease antiviral when steroid down to once a day administration |
|
|
|
|
Alternative treatment |
Nil |
|
|
|
|
Complications of treatment |
1. |
Corneal ulceration: enhanced viral replication in epithelium |
|
2. |
Ocular hypertension |
|
3. |
Allergy |
|
4. |
Toxicity |
|
|
|
Follow up |
Initially every week |
|
|
Later every 2–3 weeks |
|
|
|
|
172
|
|
THERAPY OF CORNEAL DISORDERS |
Herpetic uveitis |
|
|
|
|
|
Indication for treatment |
1. |
Symptomatic: to reduce pain |
|
2. |
Decrease disability: to improve vision |
|
3. |
Alter natural history: reduce intraocular inflammation, reduce raised |
|
|
intraocular pressure |
|
|
|
Preferred treatment |
Topical corticosteroids with antiviral cover. Prednisolone phosphate 0.5% and |
|
|
Oc acyclovir to 2/day after one week then daily at the end of the second week. |
|
|
|
Cease antiviral when steroid down to once a day administration |
|
|
|
Alternative treatment |
Nil available |
|
|
|
|
Complications of treatment |
1. |
Corneal ulceration: enhanced viral replication in epithelium |
|
2. |
Ocular hypertension |
|
3. |
Allergy |
|
4. |
Toxicity |
|
|
|
Follow up |
Initially weekly reducing to every second or third week |
|
|
|
|
Infectious crystalline keratopathy
Indication for treatment |
1. Alter natural history of disease: eradicate infection |
|
|
2. Decrease disability: reduce blinding sequelae of infection |
|
|
|
|
Preferred treatment |
Antibiotics: ciprafloxicin (3 mg/ml) or G. ofloxacin (3 mg/ml) 4/day |
|
|
for weeks |
|
|
|
|
Alternative treatment |
G.penicillin (5000 U/ml) for nutrient variant streptococci |
|
|
|
|
Complications of treatment |
1. |
Sensitivity |
|
2. |
Toxicity |
|
|
|
Follow up |
Frequent observation |
|
|
|
|
Interstitial keratitis
Indication for treatment |
To relieve symptoms of reduced vision and prevent further reduction in vision |
|
|
|
|
Preferred treatment |
1. |
Topical corticosteroids |
|
2. |
Topical cycloplegics |
|
3. |
Treatment of the underlying aetiology (although often this has no beneficial |
|
|
effect on the course of the interstitial keratitis) |
|
|
|
Alternative treatment |
Penetrating keratoplasty following treatment of the acute interstitial keratitis has |
|
|
its limitations due to thin cornea, potential for recurrent iritis |
|
|
|
|
Complications of treatment |
Prolonged corticosteroid can result in the development of secondary cataract |
|
|
and glaucoma |
|
|
|
|
Follow up |
1. |
Residual corneal haze, scarring, thinning, astigmatism and calcification |
|
|
remain following treatment |
|
2. |
Prolonged corticosteroids may result in secondary cataract and glaucoma |
|
|
|
173
CORNEA
Interstitial keratitis (non-herpetic)
Indication for treatment |
1. |
Disability: to improve vision |
|
2. |
Symptomatic: decrease pain and photophobia |
|
3. |
Alter natural history of disease: to prevent visually damaging sequelae of |
|
|
inflammation |
|
|
|
Preferred treatment |
1. |
Anti-inflammatory: prednisolone phosphate 0.5% four times/day initially – |
|
|
after three weeks titrated topical steroids against inflammatory score |
|
2. |
Antitreponemal therapy: systemic penicillin, if active disease identified |
|
|
|
Alternative treatment |
May need oral corticosteroids if scleral involvement |
|
|
|
|
Complications of treatment |
Elevated intraocular pressure |
|
|
|
|
Follow up |
Monthly until intraocular pressure confirmed to be normal on steroids then as |
|
|
required |
|
|
|
|
Intraepithelial neoplasia
Indication for treatment |
1. |
Alter natural history of disease: to avoid invasive neoplasia |
|
2. |
Disability: to improve vision |
|
|
|
Preferred treatment |
Topical mitomycin C 0.02% four times/day or 5FU 1% in pulse doses |
|
|
|
|
Alternative treatment |
1. |
Excision |
|
2. |
Excision and cryotherapy |
|
|
|
Complications of treatment |
1. |
Limbal insufficiency |
|
2. |
Recurrence |
|
|
|
Follow up |
1. Weekly during treatment |
|
|
2. |
Six monthly for the first year |
|
3. |
Every year after this |
|
|
|
Keratoconus
Indication for treatment |
Visual disability |
|
|
|
|
Preferred treatment |
1. |
Spectacle correction |
|
2. |
Contact lens correction |
|
3. |
Corneal transplantation |
|
Contact lenses are required when spectacles are not effective. Corneal |
|
|
transplantation is reserved for those who cannot use contact lenses |
|
|
|
|
Alternative treatment |
Thermokeratoplasty in some cases |
|
|
|
|
Complications of treatment |
See Complications of Contact Lens Wear and Corneal Transplantation (p. 76) |
|
|
|
|
174
|
|
THERAPY OF CORNEAL DISORDERS |
Limbal dermoid |
|
|
|
|
|
Indication for treatment |
Symptomatic: cosmesis |
|
|
|
|
Preferred treatment |
Surgical excision and lamellar corneoscleral graft |
|
|
|
|
Complications of treatment |
1. |
Infection |
|
2. |
Rejection |
|
|
|
Follow up |
1. End of week one |
|
|
2. |
End of week six |
|
3. |
End of three months |
|
4. |
End of six months |
|
5. |
End of nine months |
|
6. |
End of 12 months for suture removal |
|
|
|
Metaherpetic ulceration |
|
|
|
|
|
Indication for treatment |
1. Symptomatic: to reduce pain |
|
|
2. |
Decrease disability: to improve vision |
|
3. |
Alter natural history: achieve epithelial closure |
|
|
|
Preferred treatment |
Treat stromal inflammation to improve epithelial healing. Topical corticosteroids |
|
|
with antiviral cover. Commence prednisolone phosphate 0.5% and |
|
|
Oc acyclovir 3. Titrate steroid against inflammatory score. Reduce Oc acyclovir |
|
|
to 2/day after one week then to daily at the end of the second week. Cease |
|
|
antiviral when steroid has been reduced to once a day administration |
|
|
|
|
Alternative treatment |
Contact lens |
|
|
|
|
Complications of treatment |
1. Ocular hypertension |
|
|
2. |
Allergy |
|
3. |
Toxicity, including impaired epithelial healing |
|
|
|
Follow up |
Weekly until epithelium healed |
|
|
|
|
Papillary conjunctivitis due to contact lens wear
Indication for treatment |
|
1. |
Symptomatic: decrease discharge and discomfort |
|
|||
|
|
2. |
Decrease disability: maintain vision through continued contact lens wear |
|
|
|
|
Preferred treatment |
|
1. |
Improve lens care and cleaning |
|
|
2. |
Change to new lenses |
|
|
3. |
Decrease wearing time |
|
|
4. |
Suppress inflammation with prednisolone phosphate 0.1% four times daily |
|
|
|
|
Alternative treatment |
|
Mast cell stabiliser – disodium chromoglycolate four times a day |
|
|
|
|
|
Complications of treatment |
|
Elevated intraocular pressure |
|
|
|
|
|
Follow up |
|
Monthly when on steroids until sure that patient is not a steroid responder |
|
|
|
|
|
175
CORNEA
Papillomata of cornea and limbus
Indication for treatment |
1. |
Symptomatic: cosmesis, discharge |
|
2. |
Confirm clinical diagnosis |
|
|
|
Preferred treatment |
Excisional biopsy |
|
|
|
|
Complications of treatment |
1. |
Haemorrhage |
|
2. |
Infection |
|
3. |
Recurrence |
|
|
|
Follow up |
Weekly until healed |
|
|
|
|
Pellucid marginal degeneration
Indication for treatment |
Visual disability |
|
|
|
|
Preferred treatment |
1. |
Spectacles |
|
2. |
Contact lenses |
|
3. |
Corneal transplantation |
|
Contact lenses are used when spectacle correction is inadequate. Corneal |
|
|
transplantation is used when contact lens correction is inadequate |
|
|
|
|
Alternative treatment |
With extreme peripheral thinning an early peripheral lamellar graft may be |
|
|
preferable to a penetrating corneal graft |
|
|
|
|
Complications of treatment |
See Complications of Contact Lens Wear and Implications of Corneal |
|
|
Transplantation (pp. 76, 132) |
|
|
|
|
Persistent and recurrent corneal erosion
Indication for treatment |
Alter natural history: to prevent recurrences |
|
|
|
|
Preferred treatment |
Micropuncture |
|
|
|
|
Alternative treatment |
1. |
Bandage contact lens |
|
2. |
Therapeutic photokeratectomy |
|
|
|
Complications of treatment |
1. |
Recurrent erosion |
|
2. |
Infection |
|
|
|
Follow up |
Review as symptoms recur |
|
|
|
|
176
THERAPY OF CORNEAL DISORDERS
Pingueculum
Indication for treatment |
Symptomatic: cosmesis |
|
|
Preferred treatment |
Excision: leave sclera bare |
|
|
Complications of treatment |
Infection |
|
|
Follow up |
Review until healed |
|
|
Primary ocular HSV: blepharoconjunctivitis
Indication for treatment |
Not indicated |
Pterygium
Indication for treatment |
1. Symptomatic: cosmesis |
|
|
2. |
Reduce disability: improve vision |
|
|
|
Preferred treatment |
Excision and conjunctival autograft |
|
|
|
|
Alternative treatment |
1. |
Excision and flap repair |
|
2. |
Excision leaving sclera base |
|
3. |
Excision and irradiation |
|
|
|
Complications of treatment |
1. |
Infection |
|
2. |
Recurrence |
|
|
|
Follow up |
Weekly until healed, then at six and 12 months |
|
|
|
|
Shield ulcer
Indication for treatment |
1. |
To relieve symptoms of vernal keratoconjunctivitis |
|
2. |
To heal the ulcer |
|
3. |
Prevent secondary infective keratitis |
|
|
|
Preferred treatment |
1. |
Treatment of vernal keratoconjunctivitis |
|
2. |
Scraping of the base of the ulcer combined with a bandage soft contact lens |
|
3. |
Treat the giant papillae (as already described) |
|
|
|
Alternative treatment |
1. |
Superficial keratectomy or excimer laser may be required in recalcitrant cases |
|
|
|
Complications of treatment |
Iatrogenic corneal perforation |
|
|
|
|
Follow up |
The management is often difficult and prolonged. The shield ulcer may heal with |
|
|
corneal scarring |
|
|
|
|
177
